Your browser doesn't support javascript.
loading
UNDERSTANDING PREFERENCES FOR TYPE OF TAKE-HOME NALOXONE DEVICE: INTERNATIONAL QUALITATIVE ANALYSIS OF THE VIEWS OF PEOPLE WHO USE OPIOIDS.
Neale, Joanne; Farrugia, Adrian; Campbell, Aimee N; Dietze, Paul; Dwyer, Robyn; Fomiatti, Renae; Jones, Jermaine D; Comer, Sandra D; Fraser, Suzanne; Strang, John.
Afiliación
  • Neale J; National Addiction Centre, King's College London, London, UK.
  • Farrugia A; Australian Research Centre in Sex, Health and Society, La Trobe University, Melbourne, Australia.
  • Campbell AN; Division on Substance Use Disorders, Department of Psychiatry, New York State Psychiatric Institute and Columbia University Irving Medical Center, New York, USA.
  • Dietze P; Program on Behaviours and Health Risks, Burnet Institute, Melbourne, Australia.
  • Dwyer R; Centre for Alcohol Policy Research, School of Psychology and Public Health, La Trobe University, Melbourne, Australia.
  • Fomiatti R; Australian Research Centre in Sex, Health and Society, La Trobe University, Melbourne, Australia.
  • Jones JD; Division on Substance Use Disorders, Department of Psychiatry, New York State Psychiatric Institute and Columbia University Irving Medical Center, New York, USA.
  • Comer SD; Division on Substance Use Disorders, Department of Psychiatry, New York State Psychiatric Institute and Columbia University Irving Medical Center, New York, USA.
  • Fraser S; Australian Research Centre in Sex, Health and Society, La Trobe University, Melbourne, Australia.
  • Strang J; National Addiction Centre, King's College London, London, UK.
Drugs (Abingdon Engl) ; 29(2): 109-120, 2022.
Article en En | MEDLINE | ID: mdl-35813841
Background: Take-home naloxone (THN) is provided to non-medically trained people to reverse potential opioid overdoses. There is an increasing range of effective intramuscular (IM) and intranasal (IN) naloxone devices and this paper explores the types preferred by people who use opioids, using consumer behaviour literature to interpret the findings. Methods: Data derive from two unconnected qualitative studies involving audio-recorded semi-structured interviews. Study 1 was conducted in the United States (n=21 users of non-medical/illicit opioids). Study 2 was conducted in Australia (n=42 users of non-medical/illicit or prescribed opioids). Findings: Most participants preferred IN naloxone. Preferences were based on the ease, speed, safety and comfort of each device and underpinned by accounts of overdose revivals as being very rushed and frightening situations. Preferences related to complex interactions between the naloxone device ('product'); the knowledge, skills, experience and attitudes of the lay responder ('consumer'), and when, where and how naloxone was to be used ('usage situation'). Conclusions: THN programs should offer choice of device when possible and nasal naloxone if resources permit. Asking people which devices they prefer and why and treating them as valued consumers of naloxone products can generate insights that improve future naloxone technology and increase THN uptake and usage.
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Qualitative_research Aspecto: Patient_preference Idioma: En Revista: Drugs (Abingdon Engl) Año: 2022 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Qualitative_research Aspecto: Patient_preference Idioma: En Revista: Drugs (Abingdon Engl) Año: 2022 Tipo del documento: Article Pais de publicación: Reino Unido